Volume 2, Issue 1, March 2006
Published online: July 5, 2006
EDITORIAL

A new yaer for the Advances in Molecular Medicine

Turgay Isbir

Adv Mol Med 2006; 2(1): 5
PDF (165 KB)      
REVIEW

Platelets and lipoproteins: how much do we know about their interactions?

Derya Ozsavci

Adv Mol Med 2006; 2(1): 7-11
ABSTRACT FULL TEXT PDF (198 KB)
ORIGINAL ARTICLES

Cyclooxygenase-2 (COX-2) immunoreactivity in human endometrial carcinoma and precursor lesions: the potential use of COX-2 inhibitors in cancer chemoprevention and therapy

A. Nasir, D. Boulware, H.E. Kaiser, J.M. Lancaster, D. Coppola, P.V. Smith, A. Hakam, S.E. Siegel, B. Bodey

Adv Mol Med 2006; 2(1): 13-22
ABSTRACT FULL TEXT PDF (576 KB)

Effects of MDR1 C3435T wobble polymorphism on metastase and tumor stage in prostate cancer

Fehmi Narter, Hulya Yilmaz, Ergin Yucebas, Feridun Sengor, Nesrin Ercelen, Turgay Isbir

Adv Mol Med 2006; 2(1): 23-28
ABSTRACT FULL TEXT PDF (212 KB)

Association between angiotensin-converting enzyme gene polymorphism and circulating levels of asymmetric dimethylarginine (ADMA), NO and fibrinolytic function

Necip Ilhan, Dilara Seckin, Nevin Ilhan, Yilmaz Ozbay

Adv Mol Med 2006; 2(1): 29-35
ABSTRACT FULL TEXT PDF (237 KB)

Is paraoxonase 1 192 BB genotype risk factor for breast cancer?

Bedia Agachan, Ilhan Yaylim, H. Arzu Ergen, Soykan Arikan, Seden Kucucuk, Hulya Yilmaz, S. Umit Zeybek, Savas Bayrak, Nilufer Bozkurt, Uzay Gormus, Turgay Isbir

Adv Mol Med 2006; 2(1): 37-40
ABSTRACT FULL TEXT PDF (270 KB)

Effects of lipoprotein lipase Pvu II gene polymorphism on serum lipoprotein levels in Turkish patients with type 2 diabetes mellitus

Ozlem Kurt, Hulya Yilmaz, Turgay Isbir, Hakan Berkkan

Adv Mol Med 2006; 2(1): 41-46
ABSTRACT FULL TEXT PDF (237 KB)
ERRATUM

Erratum: "Effect of imatinib mesylate on platelet aggregation and fibrinogen binding to isolated platelets" [Adv Mol Med 2005; 1(4): 165-170]

 

Adv Mol Med 2006; 2(1): 47
PDF (177 KB)